These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 31228683)
21. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient. Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004 [TBL] [Abstract][Full Text] [Related]
22. Generation of an induced pluripotent stem cell (iPSC) line, DHMCi005-A, from a patient with CALFAN syndrome due to mutations in SCYL1. Lenz D; Staufner C; Wächter S; Hagedorn M; Ebersold J; Göhring G; Kölker S; Hoffmann GF; Jung-Klawitter S Stem Cell Res; 2019 May; 37():101428. PubMed ID: 30959346 [TBL] [Abstract][Full Text] [Related]
23. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease. Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630 [TBL] [Abstract][Full Text] [Related]
24. Reprogramming human dermal fibroblast into induced pluripotent stem cells using nonintegrative Sendai virus for transduction. Tai L; Teoh HK; Cheong SK Malays J Pathol; 2018 Dec; 40(3):325-329. PubMed ID: 30580364 [TBL] [Abstract][Full Text] [Related]
25. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions. Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879 [TBL] [Abstract][Full Text] [Related]
26. Generation of a human induced pluripotent stem cell line (MUSIi001-A) from caesarean section scar fibroblasts using Sendai viral vectors. Wattanapanitch M; Ritthaphai A; Park C; Boonkaew B; Netsrithong R; Pattanapanyasat K; Limsiri P; Vatanashevanopakorn C Stem Cell Res; 2018 Mar; 27():105-108. PubMed ID: 29367084 [TBL] [Abstract][Full Text] [Related]
27. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins. Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118 [TBL] [Abstract][Full Text] [Related]
28. Generation of induced pluripotent stem cell (iPSC) line from a 21-year-old X-linked adrenoleukodystrophy (X-ALD) patient. You YR; Son D; Kang PJ; You S; Kim DS Stem Cell Res; 2017 Dec; 25():136-138. PubMed ID: 29128817 [TBL] [Abstract][Full Text] [Related]
29. Generation of induced pluripotent stem cells from a patient with X-linked juvenile retinoschisis. Peng CH; Huang KC; Lu HE; Syu SH; Yarmishyn AA; Lu JF; Buddhakosai W; Lin TC; Hsu CC; Hwang DK; Shen CN; Chen SJ; Chiou SH Stem Cell Res; 2018 May; 29():152-156. PubMed ID: 29674172 [TBL] [Abstract][Full Text] [Related]
30. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene. Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723 [TBL] [Abstract][Full Text] [Related]
31. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation. Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986 [TBL] [Abstract][Full Text] [Related]
32. Characterization of human induced pluripotent stem cells line JLUEYEi002-A from a 48 year old healthy male. Wu H; Cheng Y; Lv Z; Liu L; Gong W; Zhang S Stem Cell Res; 2021 May; 53():102221. PubMed ID: 33677395 [TBL] [Abstract][Full Text] [Related]
33. Generation of an integration-free iPSC line (CSCRi005-A) from erythroid progenitor cells of a healthy Indian male individual. Manian KV; Bharathan SP; Maddali M; Srivastava VM; Srivastava A; Velayudhan SR Stem Cell Res; 2018 May; 29():148-151. PubMed ID: 29665501 [TBL] [Abstract][Full Text] [Related]
34. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD). Varga E; Nemes C; Bock I; Táncos Z; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A Stem Cell Res; 2017 May; 21():19-22. PubMed ID: 28677532 [TBL] [Abstract][Full Text] [Related]
35. Generation of a human iPSC line, INMi004-A, with a point mutation in CRX associated with autosomal dominant Leber congenital amaurosis. Erkilic N; Sanjurjo-Soriano C; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V Stem Cell Res; 2019 Jul; 38():101476. PubMed ID: 31247521 [TBL] [Abstract][Full Text] [Related]
37. Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease. Zheng X; Zhu Z; Chen K; Guo S; Liu T; Liu H Stem Cell Res; 2017 Aug; 23():119-121. PubMed ID: 28925360 [TBL] [Abstract][Full Text] [Related]
38. Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3. Jansch C; Günther K; Waider J; Ziegler GC; Forero A; Kollert S; Svirin E; Pühringer D; Kwok CK; Ullmann R; Maierhofer A; Flunkert J; Haaf T; Edenhofer F; Lesch KP Stem Cell Res; 2018 Apr; 28():136-140. PubMed ID: 29477591 [TBL] [Abstract][Full Text] [Related]